SCHEMBL1094446

SCHEMBL1094446

CCOCn1cccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3067280 0.88 FDPS (0.41)
Ether SCHEMBL6717167 0.82 TSHR (0.39)
SCHEMBL23873075 0.80
SCHEMBL15465485 0.79 FDPS (0.37)
SCHEMBL3303667 0.79
SCHEMBL14722200 0.78 THRB (0.39)
SCHEMBL11617 0.78 FDPS (0.33)
SCHEMBL22451154 0.78 FDPS (0.33)
Ammonia Solution, Strong SCHEMBL27898568 0.77 FDPS (0.32)
SCHEMBL19719187 0.77 CA12 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2385938-B1 SULFONAMIDE DERIVATIVES PFIZER LTD (GB) 2015-03-04 EP disclosed
EP-2385938-B1 SULFONAMIDE DERIVATIVES PFIZER LTD (GB) 2015-03-04 EP disclosed
CN-102348697-B Sulfonamide derivatives PFIZER LTD 2014-12-10 CN disclosed
US-8907101-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2014-12-09 US disclosed
US-8907101-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2014-12-09 US disclosed
US-8907101-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2014-12-09 US disclosed
US-20130338111-A1 Sulfonamide Derivatives ICAGEN, INC. (US) 2013-12-19 US disclosed
US-8541588-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2013-09-24 US disclosed
US-8541588-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2013-09-24 US disclosed
US-8541588-B2 Sulfonamide derivatives PFIZER LIMITED (GB) 2013-09-24 US disclosed
EP-1157002-A1 1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE COMPOUNDS USEFUL IN THERAPY Pfizer Limited (GB) 2001-11-28 EP disclosed
WO-2000051972-A1 1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE COMPOUNDS USEFUL IN THERAPY PFIZER LIMITED (GB) 2000-09-08 WO disclosed
WO-1997001552-A1 TRIAZOLE ANTIFUNGAL AGENTS PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-01-16 WO disclosed
EP-0491218-A1 Benzodiazepinones F. HOFFMANN-LA ROCHE AG (CH) 1992-06-24 EP disclosed
EP-0268800-B1 PHENOXYACETIC ACID DERIVATIVES AND PROCESSES FOR PREPARING THE SAME Tanabe Seiyaku Co., Ltd. (JP) 1992-02-05 EP disclosed
US-4973600-A CONGESTIVE HEART FAILURE, GOUT, DIRUETICS, HYPERURICEMIA TANABE SEIYAKU CO., LTD. (JP) 1990-11-27 US disclosed
US-4965282-A DIURETICS TANABE SEIYAKU CO., LTD. (JP) 1990-10-23 US disclosed
EP-0329326-A1 Benzodioxole derivatives and processes for preparing the same TANABE SEIYAKU CO., LTD. (JP) 1989-08-23 EP disclosed
US-4853404-A DIURETIS, SALURETICS, URICOSURETICS TANABE SEIYAKU CO., LTD. (JP) 1989-08-01 US disclosed
EP-0268800-A1 Phenoxyacetic acid derivatives and processes for preparing the same Tanabe Seiyaku Co., Ltd. (JP) 1988-06-01 EP disclosed